The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group — G.F. Samelis (2005) | RDL Network
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group
E. S. Papageorgiou, Panagiotis Tsirigotis, Meletios A Dimopoulos, Nikolaos Pavlidis, George Fountzilas, Sotirios G. Papageorgiou, Theofanis Economopoulos
Gerasimos Aravantinos, Dimitrios Bafaloukos, Meletios A Dimopoulos, C. Nikolaides, Pavlos Papakostas, Christos Kiamouris, K. Sikiotis, T. Rapsomaniki, George Fountzilas, D. Skarlos
D. Pectasides, Gerasimos Aravantinos, Haralabos P. Kalofonos, Christos Kiamouris, D. Bafaloukos, Nikolaos I. Xiros, C. Nicolaides, A. Visvikis, Meletios A Dimopoulos
Meletios A Dimopoulos, George Fountzilas, E. Papageorgiou, Christos Kiamouris, George Mantzios, Athanassios Anagnostopoulos, C. Nicolaides, Theofanis Economopoulos
Discussion(0)
No comments yet. Be the first to comment.